Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
2.57
Dollar change
-0.23
Percentage change
-8.21
%
IndexRUT P/E- EPS (ttm)-1.25 Insider Own8.82% Shs Outstand97.59M Perf Week-8.54%
Market Cap252.04M Forward P/E- EPS next Y-1.00 Insider Trans0.00% Shs Float89.41M Perf Month-9.51%
Income-138.49M PEG- EPS next Q-0.33 Inst Own38.49% Short Float9.86% Perf Quarter22.38%
Sales1.33M P/S189.50 EPS this Y12.60% Inst Trans-4.12% Short Ratio4.42 Perf Half Y115.97%
Book/sh0.53 P/B4.84 EPS next Y4.65% ROA-66.18% Short Interest8.82M Perf Year3.63%
Cash/sh0.83 P/C3.09 EPS next 5Y- ROE-124.41% 52W Range1.14 - 3.33 Perf YTD25.98%
Dividend Est.- P/FCF- EPS past 5Y30.25% ROI-92.50% 52W High-22.82% Beta0.40
Dividend TTM- Quick Ratio3.20 Sales past 5Y230.33% Gross Margin-977.03% 52W Low125.58% ATR (14)0.26
Dividend Ex-Date- Current Ratio3.20 EPS Y/Y TTM9.39% Oper. Margin-11609.08% RSI (14)51.54 Volatility8.39% 11.26%
Employees231 Debt/Eq2.02 Sales Y/Y TTM-85.63% Profit Margin-10397.15% Recom1.00 Target Price9.00
Option/ShortYes / Yes LT Debt/Eq1.89 EPS Q/Q12.30% Payout- Rel Volume1.12 Prev Close2.80
Sales Surprise103.23% EPS Surprise20.54% Sales Q/Q-97.81% EarningsMar 05 AMC Avg Volume2.00M Price2.57
SMA203.11% SMA504.48% SMA20027.07% Trades Volume2,230,955 Change-8.21%
Date Action Analyst Rating Change Price Target Change
Feb-28-24Initiated JMP Securities Mkt Outperform $4
Mar-31-23Initiated Evercore ISI Outperform
Mar-28-23Initiated B. Riley Securities Buy $8
Oct-31-22Initiated Piper Sandler Overweight $6
Aug-22-22Downgrade Goldman Neutral → Sell $2
Dec-15-21Resumed Goldman Neutral $15
Oct-15-21Resumed BTIG Research Buy $20
Jan-20-21Downgrade Robert W. Baird Outperform → Underperform $8
Jul-26-19Initiated Robert W. Baird Outperform $17
Mar-15-19Initiated Raymond James Outperform
Mar-19-24 02:49PM
Mar-06-24 01:52PM
Mar-05-24 04:05PM
Feb-29-24 04:05PM
Feb-21-24 07:00AM
07:00AM Loading…
Feb-12-24 07:00AM
Feb-08-24 04:30PM
Jan-31-24 04:00PM
Jan-17-24 07:00AM
Jan-10-24 04:30PM
Dec-07-23 04:30PM
Nov-20-23 07:00AM
Nov-08-23 06:43PM
04:05PM
Nov-07-23 04:30PM
05:00PM Loading…
Oct-12-23 05:00PM
Oct-11-23 07:10AM
Oct-10-23 07:00AM
Oct-04-23 04:05PM
Sep-27-23 04:01PM
Sep-13-23 04:30PM
Sep-05-23 07:00AM
Aug-16-23 04:30PM
Aug-15-23 07:00AM
Aug-09-23 04:05PM
Aug-07-23 07:00AM
Jul-17-23 07:00AM
Jul-04-23 06:55AM
Jun-13-23 07:00AM
Jun-08-23 07:00AM
04:30PM Loading…
Jun-01-23 04:30PM
May-24-23 05:00PM
May-16-23 06:05AM
May-11-23 04:05PM
May-03-23 07:00AM
Apr-21-23 06:05AM
Apr-17-23 07:01AM
07:00AM
Apr-10-23 07:00AM
Apr-04-23 06:30PM
Mar-15-23 07:00AM
Mar-11-23 07:18AM
Mar-09-23 04:05PM
Mar-02-23 07:00AM
Feb-27-23 04:06PM
04:05PM
Feb-14-23 07:00AM
Jan-25-23 05:34AM
Jan-24-23 07:00AM
Jan-18-23 05:30PM
Dec-15-22 04:31PM
04:30PM
Dec-13-22 07:00AM
Dec-05-22 08:30AM
Nov-21-22 07:30AM
Nov-17-22 07:00AM
Nov-10-22 09:00AM
Nov-03-22 06:04PM
04:05PM
Oct-25-22 07:01AM
07:00AM
Oct-19-22 09:43AM
07:00AM
Oct-17-22 07:00AM
Sep-20-22 07:00AM
Sep-12-22 07:00AM
Sep-01-22 04:05PM
Aug-17-22 07:00AM
Aug-15-22 04:05PM
Aug-10-22 04:05PM
Aug-04-22 04:05PM
Aug-01-22 06:38AM
Jul-26-22 07:00AM
Jul-21-22 04:06PM
04:05PM
Jul-05-22 08:00AM
Jun-10-22 08:00AM
Jun-08-22 04:05PM
08:51AM
Jun-02-22 08:00AM
May-31-22 08:00AM
May-17-22 05:00PM
May-09-22 08:32AM
May-06-22 07:30PM
May-05-22 04:05PM
May-02-22 07:00AM
Apr-27-22 04:05PM
Apr-12-22 04:35PM
Mar-30-22 07:00AM
Mar-17-22 12:14PM
Mar-10-22 04:05PM
Mar-08-22 05:15PM
Feb-24-22 07:00AM
Feb-22-22 05:34AM
Feb-08-22 04:05PM
07:00AM
Feb-07-22 10:45AM
Jan-25-22 04:05PM
Jan-13-22 07:00AM
Jan-12-22 06:15AM
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Economides VassilikiSee RemarksMay 23 '23Buy1.9012,00022,829214,058May 24 05:24 PM